|
|
| |
|
Product #
|
Description
|
Add to Cart
|
|
SRP3002
|
4-1BBL human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3006
|
AITRL human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3189
|
APRIL from mouse recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
B1309
|
BCMA/Fc Chimera from mouse >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
|
|
|
|
|
B6556
|
BCMA/Fc Chimera human >95% (SDS-PAGE), recombinant, expressed in HEK 293 cells, lyophilized powder
|
|
|
|
|
B1184
|
BCMA/Fc Chimera human >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
|
|
|
|
|
SRP3036
|
Fas Ligand human recombinant, expressed in CHO cells, ≥95% (SDS-PAGE), ≥95% (HPLC), cell culture tested
|
|
|
|
|
SRP3037
|
FAS Receptor human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
G1667
|
GITR/Fc Chimera human >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
|
|
|
|
|
G1792
|
GITR Ligand human >97% (SDS-PAGE), recombinant, expressed in baculovirus infected Sf21 cells, lyophilized powder
|
|
|
|
|
SRP3056
|
HVEM-Fc human recombinant, expressed in Hi-5 Insect cells, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
H9785
|
HVEM/Fc Chimera human >90% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
|
|
|
|
|
SRP3217
|
LIGHT from mouse recombinant, expressed in E. coli, ≥96% (SDS-PAGE), ≥96% (HPLC), cell culture tested
|
|
|
|
|
L5412
|
Anti-Lymphotoxin β Receptor antibody produced in goat affinity isolated antibody, lyophilized powder
|
|
|
|
|
L2885
|
Lymphotoxin-β Receptor/Fc Chimera human >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder, cell culture tested
|
|
|
|
|
SRP3133
|
OX40 Ligand human recombinant, expressed in Hi-5 Insect cells, ≥97% (SDS-PAGE), ≥97% (HPLC), cell culture tested
|
|
|
|
|
SRP3001
|
4-1BB Receptor human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3161
|
sRANKL human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3254
|
sRank Ligand from rat recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3160
|
sRank Receptor human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3162
|
sTNF-receptor Type I human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3163
|
sTNF-receptor Type II human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP4348
|
sTNF-RI human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
|
|
|
|
|
SRP3164
|
sTRAIL Receptor-1 (DR4) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3165
|
sTRAIL Receptor-2 (DR5) human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3166
|
TACI human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3175
|
TL-1A human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP3177
|
TNF-α human Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
SRP6047
|
TNF receptor-associated protein 1 human recombinant, expressed in E. coli, ≥95% (SDS-PAGE)
|
|
|
|
|
SRP3237
|
TRAIL from mouse recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), cell culture tested
|
|
|
|
|
T1815
|
Monoclonal Anti-Tumor Necrosis Factor Receptor II antibody produced in mouse clone 22221, purified immunoglobulin, lyophilized powder
|
|
|
|
|
T2065
|
Anti-Tumor Necrosis Factor Soluble Receptor I antibody produced in goat affinity isolated antibody, lyophilized powder
|
|
|
|
|
T2190
|
Anti-Tumor Necrosis Factor Soluble Receptor I antibody produced in goat affinity isolated antibody, lyophilized powder
|
|
|
|
|
T2440
|
Anti-Tumor Necrosis Factor Soluble Receptor II antibody produced in goat affinity isolated antibody, lyophilized powder
|
|
|
|
|
T0690
|
Tumor Necrosis Factor Soluble Receptor II (TNF sRII) from mouse >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
T7189
|
Tumor Necrosis Factor Soluble Receptor II (TNF sRII)/Fc Chimera human >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder, cell culture tested
|
|
|
|
|
T3564
|
Tumor Necrosis Factor Soluble Receptor I (TNF sRI) from mouse >97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
|
|
|
|
|
T3439
|
Tumor Necrosis Factor Soluble Receptor I (TNF sRI)/Fc Chimera human >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder, cell culture tested
|
|
|
|
|
T2315
|
Anti-Tumor Necrosis Factor Soluble Receptor Type II antibody produced in goat IgG fraction of antiserum, lyophilized powder
|
|
|
|
|
SRP3180
|
TWEAK Receptor human recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
|
|
|
|
|
|